Current and future imaging for urologic interventions

Current Opinion in Urology

Volumn 18, Issue 1, 2008, Pages 116-121

  Nascimento, Rodrigo G ^a,c   Coleman, Jonathan ^b   Solomon, Stephen B ^b  

^a Jaboatão Ultrasonography   (Brazil)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Ultra sonografia de Jaboatão ^*  (Brazil)

Author keywords

Fluoroscopy; Image guidance; Magnetic resonance imaging; Real time imaging; Threedimensional; Ultrasound

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; ELASTOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FLUOROSCOPY; HUMAN; INTERVENTIONAL RADIOLOGY; INVASIVE PROCEDURE; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PEROPERATIVE ECHOGRAPHY; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; UROLOGICAL CARE; UROLOGY;

DIAGNOSTIC IMAGING; FORECASTING; HUMANS; UROLOGIC SURGICAL PROCEDURES; UROLOGY;

EID: 37349083806     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282f1c5d3     Document Type: Review

References (48)

1. Takao H, Doi I, Watanabe T. Superselective transcatheter arterial chemoembolisation of an unresectable hepatocellular carcinoma using three-dimensional rotational angiography. Br J Radiol 2007; 80:e85-e87.
2. Hodek-Wuerz R, Martin JB, Wilhelm K, et al. Percutaneous vertebroplasty: preliminary experiences with rotational acquisitions and 3D reconstructions for therapy control. Cardiovasc Intervent Radiol 2006; 29:862-865.
3. Portis AJ, Laliberte MA, Drake S, et al. Intraoperative fragment detection during percutaneous nephrolithotomy: evaluation of high magnification rotational fluoroscopy combined with aggressive nephroscopy. J Urol 2006; 175:162-165.
4. Yusuf TE, Harewood GC, Clain JE, Levy MJ. International survey of knowledge of indications for EUS. Gastrointest Endosc 2006; 63:107-111.
5. Kondabolu S, Khan SA, Whyard J, et al. The role of endoluminal ultrasonography in urology: current perspectives. Int Braz J Urol 2004; 30:96-101.
6. Horiuchi K, Tsuboi N, Shimizu H, et al. High-frequency endoluminal ultrasonography for staging transitional cell carcinoma of the bladder. Urology 2000; 56:404-407.
7. Saga Y, Numata A, Tokumitsu M, et al. Comparative study of novel endoluminal ultrasonography and conventional transurethral ultrasonography in staging of bladder cancer. Int J Urol 2004; 11:597-601.
8. Mitterberger M, Pinggera GM, Mueller T, et al. Dynamic transurethral sonography and 3-dimensional reconstruction of the rhabdosphincter and urethra: initial experience in continent and incontinent women. J Ultrasound Med 2006; 25:315-320.
9. Artifon EL, Sakai P, Ishioka S, et al. EUS for locoregional staging of prostate cancer - a pilot study. Gastrointest Endosc 2007; 65:440-447. This paper outlines an innovative method for staging prostate cancer. EUS with flexible instruments has the potential for greater comfort and acceptability by the patients compared with rigid instruments used in conventional transrectal ultrasound.
10. Kolecki R, Schirmer B. Intraoperative and laparoscopic ultrasound. Surg Clin North Am 1998; 78:251-271.
11. Gilbert BR, Russo P, Zirinsky K, et al. Intraoperative sonography: application in renal cell carcinoma. J Urol 1988; 139:582-584.
12. Campbell SC, Fichtner J, Novick AC, et al. Intraoperative evaluation of renal cell carcinoma: a prospective study of the role of ultrasonography and histopathological frozen sections. J Urol 1996; 155:1191-1195.
13. Choyke PL, Pavlovich CP, Daryanani KD, et al. Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: a 10-year experience. J Urol 2001; 165:397-400.
14. Ukimura O, Magi-Galluzzi C, Gill IS. Real-time transrectal ultrasound guidance during laparoscopic radical prostatectomy: impact on surgical margins. J Urol 2006; 175:1304-1310. This interesting paper shows a significant reduction in positive surgical margins during laparoscopic radical prostatectomy when real-time transrectal ultrasound guidance was used. It presents an additional valuable tool during prostate surgery.
15. Lees W. Ultrasound imaging in three and four dimensions. Semin Ultrasound CT MR 2001; 22:85-105.
16. Claudon M, Tranquart F, Evans DH, et al. Advances in ultrasound. Eur Radiol 2002; 12:7-18.
17. Mitterberger M, Pinggera GM, Neuwirt H, et al. Three-dimensional ultrasonography of the urinary bladder: preliminary experience of assessment in patients with haematuria. BJU Int 2007; 99:111-116. This article compares the value of 3D ultrasound with 2D ultrasound in the diagnostic evaluation of the urinary bladder in patients with hematuria and shows that the former gives additional anatomical information and seems to allow better differentiation between benign and malignant bladder diseases.
18. Abul FT, Arun N, Abu-Assi MA, Asbeutah AM. Transrectal ultrasound guided biopsy for detecting prostate cancer: can random biopsies be reduced using the 4-dimensional technique? Int Urol Nephrol 2007; 39:517-524.
19. Dolkart L, Harter M, Snyder M. Four-dimensional ultrasonographic guidance for invasive obstetric procedures. J Ultrasound Med 2005; 24:1261-1266.
20. Pareek G, Wilkinson ER, Bharat S, et al. Elastographic measurements of in-vivo radiofrequency ablation lesions of the kidney. J Endourol 2006; 20:959-964.
21. Varghese T, Techavipoo U, Liu W, et al. Elastographic measurement of the area and volume of thermal lesions resulting from radiofrequency ablation: pathologic correlation. AJR Am J Roentgenol 2003; 181:701-707.
22. Pallwein L, Mitterberger M, Struve P, et al. Real-time elastography for detecting prostate cancer: preliminary experience. BJU Int 2007; 100:42-46. This paper presents a novel imaging tool in the detection of prostate cancer based on differences in tissue elasticity.
23. Johnson DB, Duchene DA, Taylor GD, et al. Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imaging of the thermolesion. J Endourol 2005; 19:248-252.
24. Halpern EJ, Ramey JR, Strup SE, et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 2005; 104:2373-2383.
25. Pelzer A, Bektic J, Berger AP, et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 2005; 173:1926-1929.
26. Haag P, Frauscher F, Gradl J, et al. Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J Steroid Biochem Mol Biol 2006; 102:103-113.
27. Daly B, Templeton PA. Real-time CT fluoroscopy: evolution of an interventional tool. Radiology 1999; 211:309-315.
28. Keat N. Real-time CT and CT fluoroscopy. Br J Radiol 2001; 74:1088-1090.
29. Katada K, Kato R, Anno H, et al. Guidance with real-time CT fluoroscopy: early clinical experience. Radiology 1996; 200:851-856.
30. Heck SL, Blom P, Berstad A. Accuracy and complications in computed tomography fluoroscopy-guided needle biopsies of lung masses. Eur Radiol 2006; 16:1387-1392. This is an excellent and comprehensive review of real-time CT as a guidance tool for lung masses biopsies, particularly difficult due to the movement of the lung fields during respiration. This new tool offers the possibility to overcome this limitation.
31. Daly B, Krebs TL, Wong-You-Cheong JJ, Wang SS. Percutaneous abdominal and pelvic interventional procedures using CT fluoroscopy guidance. AJR Am J Roentgenol 1999; 173:637-644.
32. Gupta A, Allaf ME, Kavoussi LR, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol 2006; 175:447-452; discussion 452-443.
33. Silverman SG, Tuncali K, Adams DF, et al. CT fluoroscopy-guided abdominal interventions: techniques, results, and radiation exposure. Radiology 1999; 212:673-681.
34. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006; 114:1277-1284. This interesting study evaluated methods capable of making MRI a potential and safe procedure in patients with selected implantable pacemaker and defibrillator systems.
35. Chan DY, Solomon S, Kim FJ, Jarret TW. Image-guided therapy in urology. J Endourol 2001; 15:105-110.
36. Rickers C, Kraitchman D, Fischer G, et al. Cardiovascular interventional MR imaging: a new road for therapy and repair in the heart. Magn Reson Imaging Clin N Am 2005; 13:465-479.
37. Silverman SG, Tuncali K, vanSonnenberg E, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy-initial experience in 23 patients. Radiology 2005; 236:716-724.
38. Denis de Senneville B, Quesson B, Moonen CT. Magnetic resonance temperature imaging. Int J Hyperthermia 2005; 21:515-531.
39. Krieger A, Susil RC, Menard C, et al. Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng 2005; 52:306-313.
40. Muntener M, Patriciu A, Petrisor D, et al. Magnetic resonance imaging compatible robotic system for fully automated brachytherapy seed placement. Urology 2006; 68:1313-1317.
41. Anastasiadis AG, Lichy MP, Nagele U, et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 2006; 50:738-748.
42. Barnes AS, Haker SJ, Mulkern RV, et al. Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. Urology 2005; 66:1319.
43. Menard C, Susil RC, Choyke P, et al. An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement. Mol Imaging 2005; 4:63-66.
44. Susil RC, Menard C, Krieger A, et al. Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. J Urol 2006; 175:113-120.
45. Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004; 34:274-292.
46. Li G, Cuilleron M, Cottier M, et al. The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Eur Urol 2006; 49:401-405.
47. Atkins M, Regan M, McDermott D, et al. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 2005; 11:3714-3721.
48. Solomon SB. Interactive images in the operating room. J Endourol 1999; 13:471-475.